Trends in Survival and Mortality of “Early” Metastatic Breast Cancer in Northern Italy Following the Introduction of Targeted Therapies
Over more than two decades, the incidence of MBC at diagnosis and early mortality both declined, accompanied by improved survival. These trends temporally coincide with the widespread adoption of targeted therapies and sustained high screening coverage, suggesting a possible combined contribution of early detection and advances in precision medicine to the observed outcomes.
Authors
- Francesco Marinelli (ORCID: https://orcid.org/0000-0002-0047-456X)
- Maria Barbara Braghiroli (ORCID: https://orcid.org/0000-0002-1017-6152)
- Guglielmo Ferrari (ORCID: https://orcid.org/0000-0003-1478-6094)
- Lucìa Mangone (ORCID: https://orcid.org/0000-0002-5089-5178)
- Isabella Bisceglia (ORCID: https://orcid.org/0000-0002-9225-781X)
- Carmine Pinto
- Fortunato Morabito
- Filippo Giovanardi
Institutions
- Azienda Sanitaria Unità Locale di Reggio Emilia (IT)
- Azienda Ospedaliera di Cosenza (IT)
- Ospedale Annunziata di Cosenza (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Cancers
- Published
- 2025-12-29
- DOI
- https://doi.org/10.3390/cancers18010108
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00